Gary Jacob
Vorstandsvorsitzender bei OKYO PHARMA LIMITED
Vermögen: 67 180 $ am 30.04.2024
Aktive Positionen von Gary Jacob
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 23.12.2020 | - |
| Independent Dir/Board Member | 23.12.2020 | - | |
| OKYO PHARMA LIMITED | Direktor/Vorstandsmitglied | 07.01.2021 | - |
| Vorstandsvorsitzender | 07.01.2021 | - |
Karriereverlauf von Gary Jacob
Ehemalige bekannte Positionen von Gary Jacob
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 15.05.2013 | 19.03.2014 |
| Vorstandsvorsitzender | 15.05.2013 | 19.03.2014 | |
| Vorsitzender | 19.03.2014 | 20.02.2024 | |
| Independent Dir/Board Member | 19.03.2014 | 20.02.2024 | |
| Präsident | 15.05.2013 | 19.03.2014 | |
| VIRPAX PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 28.04.2020 | 25.07.2022 |
| Independent Dir/Board Member | 28.04.2020 | 25.07.2022 | |
| IMMURON LIMITED | Direktor/Vorstandsmitglied | 17.04.2019 | 25.03.2020 |
| Vorstandsvorsitzender | 16.11.2018 | 25.03.2020 | |
| SYNERGY PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 29.03.2011 | 05.05.2014 |
| Vorstandsvorsitzender | 01.07.2008 | 19.12.2017 | |
| Vorsitzender | 05.05.2014 | 01.01.2018 | |
| Gründer | - | 01.01.2018 | |
| Investor Relations Kontakt | 29.03.2011 | 06.05.2014 | |
| Public Communications Contact | 24.08.2011 | 06.05.2014 | |
| Präsident | 01.07.2008 | 19.12.2017 | |
| Synergy Pharmaceuticals, Inc. /Old/ | Vorstandsvorsitzender | 01.07.2008 | 01.10.2017 |
| Vorsitzender | 01.09.2013 | 01.10.2017 | |
| Gründer | 01.07.2008 | 01.10.2017 | |
| Präsident | 01.07.2008 | 01.10.2017 | |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 01.05.2003 | 22.01.2013 |
| Vorstandsvorsitzender | 01.05.2003 | 22.01.2013 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.05.2003 | 22.01.2013 | |
| Public Communications Contact | 01.05.2003 | 22.01.2013 | |
| Präsident | 01.01.2004 | 22.01.2013 | |
| Pawfect Foods, Inc. | Direktor/Vorstandsmitglied | 11.08.2008 | 11.08.2008 |
| Präsident | - | 11.08.2008 | |
| ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Gary Jacob
| University of Wisconsin | Doctorate Degree |
| University of Missouri-St. Louis | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 14 |
| Vereinigtes Königreich | 3 |
| Australien | 2 |
Operativ
| Director/Board Member | 9 |
| Chief Executive Officer | 6 |
| President | 5 |
Sektoral
| Health Technology | 10 |
| Consumer Services | 4 |
| Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| IMMURON LIMITED | Health Technology |
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| OKYO PHARMA LIMITED | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Synergy Pharmaceuticals, Inc. /Old/ | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
| Synergy DE | |
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
| G.D. Searle LLC |
- Börse
- Insiders
- Gary Jacob
- Erfahrung
